Search Results - "Stern, A C"
-
1
Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies
Published in Psychopharmacology (2019)“…Rationale Aversive learning and memory are essential to cope with dangerous and stressful stimuli present in an ever-changing environment. When this process is…”
Get full text
Journal Article -
2
Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest
Published in Neuroscience (29-09-2010)“…Abstract The prelimbic (PL) subregion of medial prefrontal cortex has been implicated in anxiety regulation. It is unknown, however, whether PL cortex also…”
Get full text
Journal Article -
3
Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze
Published in Pharmacology, biochemistry and behavior (01-10-2008)“…Rodents re-exposed to the elevated plus-maze no longer respond to anxiolytic-like drugs, such as benzodiazepines. This phenomenon is thought to be due to…”
Get full text
Journal Article -
4
Flow Cytometry for Clinical Estimation of Circulating Hematopoietic Progenitors for Autologous Transplantation in Cancer Patients
Published in Blood (15-01-1991)“…Optimum methods of harvesting circulating hematopoietic progenitors for autologous transplantation to support myelo-ablative cancer therapy are still…”
Get full text
Journal Article -
5
Molecular identification, tissue distribution and subcellular localization of mST3GalV/GM3 synthase
Published in Glycobiology (Oxford) (01-04-2000)“…A molecular screen for a mouse homologue of a Drosophila carbohydrate binding protein, called Gliolectin, yielded a cDNA encoding mST3GalV/GM3 synthase…”
Get full text
Journal Article -
6
Efficacy and security of ivermectin given orally to rats naturally infected with Syphacia spp., Giardia spp. and Hymenolepis nana
Published in Laboratory animals (London) (01-07-2015)“…The results of this study show that the oral administration of ivermectin (48 mg/L) repeatedly for 72 h used in accordance with the present protocol is a safe…”
Get full text
Journal Article -
7
-
8
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Accelerates Neutrophil and Monocyte Recovery After Allogeneic T-Cell-Depleted Bone Marrow Transplantation
Published in Blood (01-03-1992)“…In a prospective randomized study, five European transplant centers compared recombinant human granulocyte-macro-phage colony-stimulating factor (rhGM-CSF;…”
Get full text
Journal Article -
9
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma
Published in Journal of clinical oncology (01-05-1990)“…High-dose administration of anticancer agents is attractive both on theoretic and clinical grounds. Yet, high-dose regimens are usually used as salvage…”
Get more information
Journal Article -
10
Protein synthesis in dorsal hippocampus supports the drug tolerance induced by prior elevated plus-maze experience
Published in Neuroscience (14-04-2011)“…Abstract Tolerance to the anxiolytic-like effect of drugs may develop because of a memory derived from prior experience in certain apparatuses such as the…”
Get full text
Journal Article -
11
Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy
Published in The Lancet (British edition) (24-08-1991)Get more information
Journal Article -
12
Human Monoclonal Antibodies Neutralizing Cytomegalovirus (CMV) for Prophylaxis of CMV Disease: Report of a Phase I Trial in Bone Marrow Transplant Recipients
Published in The Journal of infectious diseases (01-06-1991)“…The safety and pharmacokinetics of the two neutralizing human IgG1 monoclonal antibodies to cytomegalovirus (CMV) SDZ89-104 and 89-109 in bonemarrowtransplant…”
Get full text
Journal Article -
13
A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma
Published in Cancer research (Chicago, Ill.) (1991)“…In a placebo-controlled double-blind dose-finding trial, 15 patients with ovarian cancer stage III or IV received daily s.c. 1.5, 3, or 6 micrograms/kg…”
Get full text
Journal Article -
14
Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs
Published in Cancer (15-11-1993)“…Administration of granulocyte-macrophage colony stimulating factor (GM-CSF) is followed by a rapid increase in the proliferative activity of the hematopoietic…”
Get more information
Journal Article -
15
Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever
Published in European journal of cancer (1990) (1990)“…30 patients with chemotherapy-related leukopenia (white cells 1.0 x 10(9)/l or lower) and fever (temperature 38.5 degrees C or higher) were treated in a…”
Get more information
Journal Article -
16
Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas
Published in Seminars in oncology (01-12-1994)Get more information
Journal Article -
17
GM-CSF: intravenous versus subcutaneous treatment
Published in Leukemia (01-07-1990)Get more information
Journal Article -
18
In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells
Published in Leukemia (01-11-1991)“…Granulocyte-macrophage colony-stimulating factor, (GM-CSF) was given at 8 micrograms/kg daily by continuous i.v. infusion for 72 h to six patients with acute…”
Get more information
Journal Article -
19
-
20
Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy
Published in Leukemia research (01-02-1993)“…Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was given to 60 patients, in a double-blind, non-prophylactic study of already…”
Get more information
Journal Article